Tumourigenicity and radiation resistance of mesenchymal stem cells

Acta Oncologica

Volumn 51, Issue 5, 2012, Pages 669-679

  D'Andrea, Filippo P ^a   Horsman, Michael R ^a   Kassem, Moustapha ^b   Overgaard, Jens ^a   Safwat, Akmal ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INTERSTITIAL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL FUNCTION; CELL GROWTH; CLONOGENIC ASSAY; CONTROLLED STUDY; DOSE RESPONSE; EXTRACELLULAR MATRIX; GENE; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE MAPPING; HUMAN; HUMAN CELL; IRRADIATION; LOX GENE; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; PLAU GENE; PLAUR GENE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RADIOSENSITIVITY; TUMOR CELL CULTURE; TUMOR CELL LINE;

ADULT; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MESENCHYMAL STEM CELLS; NEOPLASMS; NEOPLASTIC STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RADIATION TOLERANCE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84862107535     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.636752     Document Type: Article

References (29)

1. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756-60.
2. Phillips TM, McBride WH, Pajonk F. The response of CD24-/low/CD44 - breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006;98:1777-85.
3. Rich JN. Cancer stem cells in radiation resistance. Cancer Res 2007;67:8980.
4. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, et al. A distinct "side population" of cells with high drug effl ux capacity in human tumor cells. Proc Natl Acad Sci USA 2004;101:14228-33.
5. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005;5:275-84.
6. Serakinci N, Guldberg P, Burns JS, Abdallah B, Schrodder H, Jensen T, et al. Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 2004;23:5095-8.
7. Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, Rattan SI, et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 2002;20:592-6.
8. D'Andrea FP, Safwat A, Kassem M, Gautier L, Overgaard J, Horsman MR. Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance. Radiother Oncol 2011;99:373-8.
9. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci 2003;100:15178-83.
10. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identifi cation of tumorigenic breast cancer cells. Proc Natl Acad Sci 2003;100:3983-8.
11. Strauss R, Li Z-Y, Liu Y, Beyer I, Persson J, Sova P, et al. Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS ONE 2011;6.
12. El-Guendy N, Zhao Y, Gurumurthy S, Burikhanov R, Rangnekar VM. Identifi cation of a unique core domain of Par-4 suffi cient for selective apoptosis induction in cancer cells. Mol Cell Biol 2003;23:5516-25.
13. Montuori N, Carriero MV, Salzano S, Rossi G, Ragno P. The cleavage of the urokinase receptor regulates its multiple functions. J Biol Chem 2002;277:46932-9.
14. Gondi CS, Kandhukuri N, Dinh DH, Gujrati M, Rao JS. Downregulation of uPAR and uPA activates caspase mediated apoptosis, inhibits the PI3k/AKT pathway. Int J Oncol 2007;31:19.
15. Sidenius N, Blasi F. The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy. Cancer Metastasis Rev 2003;22:205-22.
16. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463.
17. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003;114:33-45.
18. Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 2005;120:303-13.
19. Sun T, Gao Y, Tan W, Ma S, Zhang X, Wang Y, et al. Haplotypes in matrix metalloproteinase gene cluster on chromosome 11q22 contribute to the risk of lung cancer development and progression. Clin Cancer Res 2006;12:7009-17.
20. Bouez C, Reynaud C, Noblesse E, Thépot A, Gleyzal C , Kanitakis J, et al. The Lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model. Clin Cancer Res 2006;12:1463-9.
21. Villadangos JA. Presentation of antigens by MHC class II molecules: Getting the most out of them. Mol Immunol 2001;38:329-46.
22. Glew SS, Duggan-Keen M, Cabrera T, Stern PL. HLA class II antigen expression in human papillomavirus-associated cervical cancer. Cancer Res 1992;52:4009-16.
23. E l-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25.
24. Wajant H. The Fas signaling pathway: More than a paradigm. Science 2002;296:1635-6.
25. Zhang Z, Li M, Wang H, Agrawal S, Zhang R. Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy. Proc Natl Acad Sci 2003;100:11636-41.
26. Tomasini R, Seux M, Nowak J, Bontemps C, Carrier A, Dagorn JC, et al. TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity. Oncogene 2005;24:8093-104.
27. Wu GS, Burns TF, McDonald ER 3rd, Jiang W, Meng R, Krantz ID, et al. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 1997;17:141.
28. Bauskin AR, Brown DA, Kuffner T, Johnen H, Luo XW, Hunter M, et al. Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Res 2006;66:4983-6.
29. Maeda S, Nobukuni T, Shimo-Onoda K, Hayashi K, Yone K, Komiya S, et al. Sortilin is upregulated during osteoblastic differentiation of mesenchymal stem cells and promotes extracellular matrix mineralization. J Cell Physiol 2002; 193:73-9.